14158 Results (Page 37 of 567)
All Market Research Reports
India Cardiac Pacemakers Market Analysis
The India Cardiac Pacemakers Market was valued at $73.60 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $112.13 Mn by 2030. The key drivers of this industry include medical tourism, rising prevalence, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
South Africa Cardiac Pacemakers Market Analysis
The South Africa Cardiac Pacemakers Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 4.43% from 2023 to 2030, to $35.63 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular disease, the increasing aging population, and advancements in technology. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Kenya Cardiac Pacemakers Market Analysis
The Kenya Cardiac Pacemakers Market was valued at $2.83 Mn in 2023 and is predicted to grow at a CAGR of 4.3% from 2023 to 2030, to $3.80 Mn by 2030. The key drivers of this industry include an aging population, technological innovations, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Egypt Cardiac Pacemakers Market Analysis
The Egypt Cardiac Pacemakers Market was valued at $11.33 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $15.63 Mn by 2030. The key drivers of this industry include increasing incidence, aging population, and healthcare investment. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Vietnam Cardiac Pacemakers Market Analysis
The Vietnam Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 3.43% from 2023 to 2030, to $25.62 Mn by 2030. The key drivers of this industry include increasing disease burden, aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Singapore Cardiac Pacemakers Market Analysis
The Singapore Cardiac Pacemakers Market was valued at $4.86 Mn in 2023 and is predicted to grow at a CAGR of 3.8% from 2023 to 2030, to $6.31 Mn by 2030. The key drivers of this industry include increasing prevalence, healthcare expenditure, and a rising aging population. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Philippines Cardiac Pacemakers Market Analysis
The Philippines Cardiac Pacemakers Market was valued at $8.90 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030, to $11.48 Mn by 2030. The key drivers of this industry include healthcare expenditure, aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Malaysia Cardiac Pacemakers Market Analysis
The Malaysia Cardiac Pacemakers Market was valued at $6.51 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $8.22 Mn by 2030. The key drivers of this industry include healthcare expenditure, aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Japan Cardiac Pacemakers Market Analysis
The Japan Cardiac Pacemakers Market was valued at $251.55 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030, to $324.40 Mn by 2030. The key drivers of this industry include the aging population, healthcare infrastructure, and increased preference for minimally invasive processes. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Indonesia Cardiac Pacemakers Market Analysis
The Indonesia Cardiac Pacemakers Market was valued at $24.28 Mn in 2023 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030, to $30.27 Mn by 2030. The key drivers of this industry include the growing aging population, technological advancements, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
China Cardiac Pacemakers Market Analysis
The China Cardiac Pacemakers Market was valued at $325.32 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $448.68 Mn by 2030. The key drivers of this industry include an increasing aging population, healthcare expenditure, and growing awareness. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
UAE Cardiac Pacemakers Market Analysis
The UAE Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $26.99 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, advancements in technology, and government support. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Saudi Arabia Cardiac Pacemakers Market Analysis
The Saudi Arabia Cardiac Pacemakers Market was valued at $68.80 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $94.89 Mn by 2030. The key drivers of this industry include government initiatives, growing aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
UK Cardiac Pacemakers Market Analysis
The UK Cardiac Pacemakers Market was valued at $105.22 Mn in 2023 and is predicted to grow at a CAGR of 1.2% from 2023 to 2030, to $114.38 Mn by 2030. The key drivers of this industry include increasing aging population, advancements in technology, and supportive government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Spain Cardiac Pacemakers Market Analysis
The Spain Cardiac Pacemakers Market was valued at $78.11 Mn in 2023 and is predicted to grow at a CAGR of 2.2% from 2023 to 2030, to $90.96 Mn by 2030. The key drivers of this industry include an aging population, advancements in technology, and healthcare expenditure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Germany Cardiac Pacemakers Market Analysis
The Germany Cardiac Pacemakers Market was valued at $148.12 Mn in 2023 and is predicted to grow at a CAGR of 1.4% from 2023 to 2030, to $163.26 Mn by 2030. The key drivers of this industry include the prevalence of cardiovascular disease, the aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Mexico Cardiac Pacemakers Market Analysis
The Mexico Cardiac Pacemakers Market was valued at $60.70 Mn in 2023 and is predicted to grow at a CAGR of 3.45% from 2023 to 2030, to $76.97 Mn by 2030. The key drivers of this industry include the aging population, rising chronic disease, and medical tourism. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Brazil Cardiac Pacemakers Market Analysis
The Brazil Cardiac Pacemakers Market was valued at $101.17 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $134.94 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, the aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
France Cardiac Pacemakers Market Analysis
The France Cardiac Pacemakers Market was valued at $111.29 Mn in 2023 and is predicted to grow at a CAGR of 2.2% from 2023 to 2030, to $129.60 Mn by 2030. The key drivers of this industry include the aging population, technological advancements, and healthcare system. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Brazil Biosensors Market Analysis
The Brazil Biosensors Market was valued at $722.5 Mn in 2023 and is predicted to grow at a CAGR of 9% from 2023 to 2030, to $1320.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing demand for Point-of-Care (POC) testing. The prominent players of the Brazil Biosensors Market are Biosensor Indústria e Comércio, BioCen Do Brazil, Abbott Laboratories, Medtronic, and Siemens Healthcare, among others.
Canada Biosensors Market Analysis
The Canada Biosensors Market was valued at $2312 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $3962.4 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, technological advancements, and growing demand for Point-of-Care (POC) testing. The prominent players of the Canada Biosensors Market are Nicoya Lifesciences, SomaDetect, Biosensors International, Nix Biosensors, Nova Biomedical Corporation, and Abbott Laboratories, among others.
UK Clinical Nutrition Market Analysis
The UK Clinical Nutrition Market was valued at $797.4 Mn in 2023 and is projected to grow at a CAGR of 3.34% from 2023 to 2023, to $1003.6 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others
US Clinical Nutrition Market Analysis
The US Clinical Nutrition Market was valued at $12,881.4 Mn in 2023 and is projected to grow at a CAGR of 3.34% from 2023 to 2023, to $16,212.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others.
Canada Clinical Nutrition Market Analysis
The Canada Clinical Nutrition Market was valued at $2453.6 Mn in 2023 and is projected to grow at a CAGR of 5.34% from 2023 to 2023, to $3531.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Vicore Pharma Holding, Cambrooke Therapeutics, Abbott Nutrition, Bayer AG, Nestle among others.
Spain Lysosomal Storage Disease Therapeutics Market Analysis
Spain lysosomal storage disease therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The rise in lysosomal diseases, greater public awareness of unusual lysosomal storage disorders, increased research and development for diagnostics, and increased drug development for treating lysosomal diseases are the main drivers impacting the market for lysosomal storage disease treatments. Major global players in this market are Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd), Amicus Therapeutics, Inc, Alexion Pharmaceuticals, Inc, Sigilon Therapeutics, Inc, and Orphazyme A/S are some of the companies that participate in this industry.
